Title

Biomarker Application for Drug Development in Asthma and COPD. Focus on Airway Inflammation in Asthma

Authors

Philip Emanuel Silkoff, MD, Centocor R&D Inc.

Document Type

Presentation

Publication Date

5-25-2011

Comments

Overall Goals and Objectives:

1. Learn about biomarkers that have utility in sub-setting asthma.

2. Learn how to use biomarkers to select populations for clinical trials of new therapeutics in asthma.

3. Learn how these biomarkers can be used clinically in individual patients.

Abstract

Dr. Philip Silkoff is currently a Senior Director in Pulmonary Medicine/Immunology at Centocor R&D Inc. (Johnson and Johnson Pharmaceutical Research and Development.) Previously, he was the Medical Director and an Associate Professor at the National Jewish Medical Research Center and University of Colorado Health Sciences Center, Denver, CO. He was awarded Clinician of the Year at the National Jewish Medical and Research Center for many years. His clinical and research interests are the biomarkers of asthma diagnosis and treatment.

Presentation runs 1 hour and 6 minutes.

Recommended Citation

Silkoff, MD, Philip Emanuel, "Biomarker Application for Drug Development in Asthma and COPD. Focus on Airway Inflammation in Asthma" (2011). Division of Pulmonary and Critical Care Medicine Presentations and Grand Rounds. Presentation 18.
https://jdc.jefferson.edu/pulmcritcaregrandrounds/18